Search results
Heart disease: Moderate intake of choline may help reduce risk
Medical News Today· 1 day agoCholine is a nutrient essential for heart health and brain function and is found in many foods like...
Ventyx Biosciences stock holds at Neutral amid competitor's trial results By Investing.com
Investing.com· 8 hours agoThis drug is seen as a direct rival to Ventyx's own NLRP3 inhibitor, VTX3232. NodThera's NT-0796...
New Analysis Finds Millions of People on Statins May Not Need Them
Healthline via AOL· 1 day agocardiovascular disease.” This includes equations like PCE and PREVENT. New analysis may be more...
Statins for heart disease prevention could be recommended for far fewer Americans if new risk...
Medical Xpress· 3 days agoIf national guidelines are revised to incorporate a new risk equation, about 40% fewer people could...
Man died at Tacoma immigration detention center of natural causes, medical examiner says
Tacoma News Tribune via Yahoo News· 2 days agoCharles Leo Daniel, a citizen of Trinidad and Tobago, died March 7 of hypertensive and ...
Carl Weathers Honored by Directors Guild Foundation in Renaming of Golf Tournament
The Wrap via Yahoo News· 1 day ago"We celebrate the invaluable contributions of this remarkable man that has enriched our community,"...
Jun 07 2024 This Week in Cardiology
Medscape· 7 days agoFirst, I want to offer huge thank you to Professor Andrew Clark and the British Cardiovascular Society (BCS) for inviting me to give the Paul Wood...
Can statins help prevent cancer? New study offers clues
MedicalNewsToday via AOL· 5 days agoA recent study found that using the statin pitavastatin may assist in blocking a particular...
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives $9.33 Consensus Target Price from Analysts
ETF DAILY NEWS· 2 days agoEsperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) has earned an average rating of “Hold” from the five analysts that are currently covering the company, MarketBeat reports. Three research ...
Esperion Therapeutics Target of Unusually High Options Trading (NASDAQ:ESPR)
ETF DAILY NEWS· 2 days agoEsperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw some unusual options trading activity on Monday. Investors bought 5,316 call options on the stock. This represents an increase ...